A Family of Drug Transporters: the Multidrug Resistance-Associated Proteins

作者: P. Borst , R. Evers , M. Kool , J. Wijnholds

DOI: 10.1093/JNCI/92.16.1295

关键词: Multidrug Resistance-Associated Protein 1GlucuronateMembrane transport proteinBiochemistryBiologyOrganic anion transporter 1Membrane transportMultidrug resistance-associated protein 2Drug resistanceMultidrug Resistance-Associated Proteins

摘要: The human multidrug resistance-associated protein (MRP) family currently has seven members. ability of several these membrane proteins to transport a wide range anticancer drugs out cells and their presence in many tumors make them prime suspects unexplained cases drug resistance, although proof that they contribute clinical resistance is still lacking. Recent studies have begun clarify the function MRP MRPs are organic anion transporters; i.e., anionic drugs, exemplified by methotrexate, neutral conjugated acidic ligands, such as glutathione (GSH), glucuronate, or sulfate. However, MRP1, MRP2, MRP3 can also cause not known be ligands transporting together with free GSH. MRP1 even confer arsenite MRP2 cisplatin, again probably compounds complexes MRP4 overexpression associated high-level nucleoside analogues 9-(2-phosphonylmethoxyethyl) adenine azidothymidine, both which used anti-human immunodeficiency virus drugs. may, therefore, role against cancer chemotherapy. Mice without Mrp1, high-affinity leukotriene C(4) transporter, an altered response inflammatory stimuli but otherwise healthy fertile. major transporter responsible for secretion bilirubin glucuronides into bile, humans develop mild liver disease Dubin-Johnson syndrome. physiologic functions other known. Whether long-term inhibition tolerated (assuming suitable inhibitors will found) remains determined.

参考文章(92)
Sikic Bi, Pharmacologic approaches to reversing multidrug resistance. Seminars in Hematology. ,vol. 34, pp. 40- 47 ,(1997)
James M. Ford, Jin-Ming Yang, William N. Hait, P-glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal. Cancer treatment and research. ,vol. 87, pp. 3- 38 ,(1996) , 10.1007/978-1-4613-1267-3_1
Takeshi Uchiumi, Mayumi Ono, Morimasa Wada, Koji Koike, Michihiko Kuwano, Takeshi Kawabe, Toshiya Tanaka, Shin Ichi Akiyama, Satoshi Toh, A Canalicular Multispecific Organic Anion Transporter (cMOAT) Antisense cDNA Enhances Drug Sensitivity in Human Hepatic Cancer Cells Cancer Research. ,vol. 57, pp. 5475- 5479 ,(1997)
Olivier Le Saux, Zsolt Urban, Cordula Tschuch, Katalin Csiszar, Barbara Bacchelli, Daniela Quaglino, Ivonne Pasquali-Ronchetti, F. Michael Pope, Allan Richards, Sharon Terry, Lionel Bercovitch, Anne de Paepe, Charles D. Boyd, Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum Nature Genetics. ,vol. 25, pp. 223- 227 ,(2000) , 10.1038/76102
Germana Rappa, Alan C. Sartorelli, Richard A. Flavell, Aurelio Lorico, Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Research. ,vol. 57, pp. 5232- 5237 ,(1997)
I Leier, G Jedlitschky, U Buchholz, S P Cole, R G Deeley, D Keppler, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. Journal of Biological Chemistry. ,vol. 269, pp. 27807- 27810 ,(1994) , 10.1016/S0021-9258(18)46856-1
C R Lincke, J J Smit, T van der Velde-Koerts, P Borst, Structure of the human MDR3 gene and physical mapping of the human MDR locus. Journal of Biological Chemistry. ,vol. 266, pp. 5303- 5310 ,(1991) , 10.1016/S0021-9258(19)67788-4
John D Schuetz, Michele C Connelly, Daxi Sun, Sheela G Paibir, Patricia M Flynn, RV Srinivas, Alok Kumar, Arnold Fridland, None, MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nature Medicine. ,vol. 5, pp. 1048- 1051 ,(1999) , 10.1038/12487